Cyhoeddiadau
2024
- Lowe, J. et al. 2024. Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial. The Lancet Respiratory Medicine (10.1016/S2213-2600(24)00079-1)
- Gallacher, D. J., Zhang, L., Aboklaish, A. F., Mitchell, E., Wach, R., Marchesi, J. R. and Kotecha, S. 2024. Baseline azithromycin resistance in the gut microbiota of preterm born infants. Pediatric Research 95, pp. 205-212. (10.1038/s41390-023-02743-7)
2023
2022
2019
- Qamar, M. U., Walsh, T. R., Toleman, M. A., Tyrrell, J. M., Saleem, S., Aboklaish, A. and Jahan, S. 2019. Dissemination of genetically diverse NDM-1, -5, -7 producing-Gram-negative pathogens isolated from pediatric patients in Pakistan. Future Microbiology 14(8) (10.2217/fmb-2019-0012)
- Juhas, M. et al. 2019. In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy 74(4), pp. 944-952. (10.1093/jac/dky546)
- Tyrrell, J. M., Aboklaish, A. F., Walsh, T. R., Vaara, T. and Vaara, M. 2019. The polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii. Peptides 112, pp. 149-153. (10.1016/j.peptides.2018.12.006)
2018
2016
- Beeton, M. L., Maxwell, N. C., Chalker, V. J., Brown, R. J., Aboklaish, A. F. and Spiller, O. B. 2016. Isolation of separate Ureaplasma species from endotracheal secretions of twin patients. Pediatrics 138(2), article number: e20160565. (10.1542/peds.2016-0565)
- Aboklaish, A., Ahmed, S., McAllister, D., Cassell, G., Zheng, X. and Spiller, O. B. 2016. Differential recognition of the Multiple Banded Antigen isoforms across Ureaplasma parvum and Ureaplasma urealyticum species by monoclonal antibodies. Journal of Microbiological Methods 127, pp. 13-19. (10.1016/j.mimet.2016.05.015)
2014
- Aboklaish, A., Dordet-Frisoni, E., Citti, C., Toleman, M. A., Glass, J. I. and Spiller, O. B. 2014. Random insertion and gene disruption via transposon mutagenesis of Ureaplasma parvum using a mini-transposon plasmid. International Journal of Medical Microbiology 304(8), pp. 1218-1225. (10.1016/j.ijmm.2014.09.003)
- Aboklaish, A. F. 2014. The development of methods to investigate the mechanisms underlying serum resistance of Ureaplasma species. PhD Thesis, Cardiff University.
2013
- Triantafilou, M., De Glanville, B., Aboklaish, A. F., Spiller, O. B., Kotecha, S. and Triantafilou, K. 2013. Synergic activation of Toll-Like Receptor (TLR) 2/6 and 9 in response to ureaplasma parvum & urealyticum in human amniotic epithelial cells. PLoS ONE 8(4), article number: e61199. (10.1371/journal.pone.0061199)
Articles
- Lowe, J. et al. 2024. Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial. The Lancet Respiratory Medicine (10.1016/S2213-2600(24)00079-1)
- Gallacher, D. J., Zhang, L., Aboklaish, A. F., Mitchell, E., Wach, R., Marchesi, J. R. and Kotecha, S. 2024. Baseline azithromycin resistance in the gut microbiota of preterm born infants. Pediatric Research 95, pp. 205-212. (10.1038/s41390-023-02743-7)
- Kotecha, E. et al. 2023. Association of early and current life factors with telomere length in preterm-born children. PLoS ONE 18(11), article number: e0293589. (10.1371/journal.pone.0293589)
- Tyrrell, J. M. et al. 2022. 'Superbugs': raising public awareness of antimicrobial resistance through a pop-up science shop. Research for All 6(1), pp. 1-21. (10.14324/RFA.06.1.06)
- Qamar, M. U., Walsh, T. R., Toleman, M. A., Tyrrell, J. M., Saleem, S., Aboklaish, A. and Jahan, S. 2019. Dissemination of genetically diverse NDM-1, -5, -7 producing-Gram-negative pathogens isolated from pediatric patients in Pakistan. Future Microbiology 14(8) (10.2217/fmb-2019-0012)
- Juhas, M. et al. 2019. In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy 74(4), pp. 944-952. (10.1093/jac/dky546)
- Tyrrell, J. M., Aboklaish, A. F., Walsh, T. R., Vaara, T. and Vaara, M. 2019. The polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii. Peptides 112, pp. 149-153. (10.1016/j.peptides.2018.12.006)
- Carretto, E. et al. 2018. Clinical validation of sensitest colistin, a broth microdilution-based method to evaluate colistin MICs. Journal of Clinical Microbiology 56(4), article number: e01523-17. (10.1128/JCM.01523-17)
- Beeton, M. L., Maxwell, N. C., Chalker, V. J., Brown, R. J., Aboklaish, A. F. and Spiller, O. B. 2016. Isolation of separate Ureaplasma species from endotracheal secretions of twin patients. Pediatrics 138(2), article number: e20160565. (10.1542/peds.2016-0565)
- Aboklaish, A., Ahmed, S., McAllister, D., Cassell, G., Zheng, X. and Spiller, O. B. 2016. Differential recognition of the Multiple Banded Antigen isoforms across Ureaplasma parvum and Ureaplasma urealyticum species by monoclonal antibodies. Journal of Microbiological Methods 127, pp. 13-19. (10.1016/j.mimet.2016.05.015)
- Aboklaish, A., Dordet-Frisoni, E., Citti, C., Toleman, M. A., Glass, J. I. and Spiller, O. B. 2014. Random insertion and gene disruption via transposon mutagenesis of Ureaplasma parvum using a mini-transposon plasmid. International Journal of Medical Microbiology 304(8), pp. 1218-1225. (10.1016/j.ijmm.2014.09.003)
- Triantafilou, M., De Glanville, B., Aboklaish, A. F., Spiller, O. B., Kotecha, S. and Triantafilou, K. 2013. Synergic activation of Toll-Like Receptor (TLR) 2/6 and 9 in response to ureaplasma parvum & urealyticum in human amniotic epithelial cells. PLoS ONE 8(4), article number: e61199. (10.1371/journal.pone.0061199)
Conferences
Thesis
Supervision
Past projects
